Consistent with these observations, AP2M1 showed higher co‐expression with Notch pathway genes in malignant HSPCs compared to normal HSPCs, further supporting the relationship between AP2M1 and Notch signaling in AML (Figure 5F). The gene discussed is AP2M1; the disease is acute myeloid leukemia.